Cargando…
516. A Systematic Literature Review Evaluating Real-World Use of Nirmatrelvir-Ritonavir for the Prevention of COVID-19-Related Hospitalization and Death
BACKGROUND: Nirmatrelvir-ritonavir (NMV-r) is an oral antiviral medication used for the treatment of mild-to-moderate COVID-19 in patients aged 12 years or older at high risk of progression to severe disease and hospitalization. Following real-world utilization beginning in late 2021, millions of pa...
Autores principales: | Cha-Silva, Ashley S, Gavaghan, Meghan B, Nguyen, Jennifer L, Alexander-Parrish, Ronika, Yang, Jingyan, Patel, Jaymin, Garner, Denise A, Stanford, Richard, Meier, Genevieve |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677322/ http://dx.doi.org/10.1093/ofid/ofad500.585 |
Ejemplares similares
-
Real-world use of nirmatrelvir–ritonavir: who benefits?
por: Molina, Kyle C, et al.
Publicado: (2023) -
The Antiviral Effect of Nirmatrelvir/Ritonavir during COVID-19 Pandemic Real-World Data
por: Petrakis, Vasilios, et al.
Publicado: (2023) -
Nirmatrelvir-ritonavir for COVID-19
por: McDonald, Emily G, et al.
Publicado: (2022) -
Nirmatrelvir and ritonavir for COVID-19
Publicado: (2022) -
Real-World Effectiveness of Nirmatrelvir-Ritonavir and Its Acceptability in High-Risk COVID-19 Patients
por: Kim, Min-Kyung, et al.
Publicado: (2023)